GUARDANT HEALTH, INC. (GH) FY2026 Q2 P&L / Income Statement

GUARDANT HEALTH, INC. (GH) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Revenue

334,978,000 US dollars

Cost of revenue

115,949,000 US dollars

Gross profit (calculated)

219,029,000 US dollars

Operating expenses (calculated)

348,147,000 US dollars

Loss from operations

negative 129,118,000 US dollars

Other income (expense), net (calculated)

9,161,000 US dollars

Loss before provision for income taxes

negative 119,957,000 US dollars

Provision for income taxes

185,000 US dollars

Net loss

negative 120,142,000 US dollars

Oncology

219,105,000 US dollars

Biopharma and data

60,947,000 US dollars

Screening

52,866,000 US dollars

Licensing and other

2,060,000 US dollars

Research and development expense

96,533,000 US dollars

Sales and marketing expense

189,954,000 US dollars

General and administrative expense

61,660,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.